Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Developmental hemostasis: age-specific differences in the levels of hemostatic proteins.J Thromb Haemost. 2013; 11: 1850-1854
- Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report.Hemasphere. 2019; 3: e286
- A systematic review of definitions and reporting of bleeding outcome measures in haemophilia.Haemophilia. 2015; 21: 731-735
- Haemophilia A carriers experience reduced health-related quality of life.Haemophilia. 2015; 21: 761-765
- Assay discrepancy in mild haemophilia A.Eur J Haematol Suppl. 2014; 76: 48-50
- Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.Semin Thromb Hemost. 2013; 39: 272-282
- Protocols for the treatment of haemophilia and von Willebrand disease.Haemophilia. 2000; 6: 84-93
- Congenital bleeding disorders of the vitamin K-dependent clotting factors.Vitam Horm. 2008; 78: 281-374
- Congenital factor XI deficiency: an update.Semin Thromb Hemost. 2013; 39: 621-631
- Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.Haemophilia. 2015; 21: 496-501
- Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.Semin Thromb Hemost. 2005; 31: 577-601
- von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Hematology Am Soc Hematol Educ Program. 2013; 2013: 254-260
- von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the national heart, Lung, and blood Institute (NHLBI) Expert panel report (USA).Haemophilia. 2008; 14: 171-232
- Surgery in patients with inherited bleeding disorders.Anaesthesia. 2015; 70: 112-120.e39-40
- Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.Br J Haematol. 2009; 145: 24-33
- Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients.Am J Clin Pathol. 2013; 139: 812-816
- Disseminated intravascular coagulation in paediatrics.Arch Dis Child. 2017; 102: 187-193
- Vitamin K deficiency bleeding in infants and children.Semin Thromb Hemost. 1995; 21: 317-329
- Bleeding and clotting disorders in pediatric liver disease.Hematology Am Soc Hematol Educ Program. 2011; 2011: 170-177
- Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.Blood. 2010; 116: 878-885
- Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.Gastroenterology. 2001; 121: 131-139
- Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests.J Thromb Haemost. 2012; 10: 2116-2122
- Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.Liver Int. 2006; 26: 173-181
- Prothrombin complex concentrates for coagulopathy in liver disease: single-center, clinical experience in 105 patients.Hepatol Commun. 2019; 3: 513-524
- Comparison of fresh-frozen plasma, four-factor prothrombin complex concentrates, and recombinant factor VIIa to facilitate procedures in critically Ill patients with coagulopathy from liver disease: a retrospective cohort study.Pharmacotherapy. 2016; 36: 1047-1054
- Transfusion strategies in patients with cirrhosis.Eur J Haematol. 2020; 104: 15-25
- Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients.J Pediatr. 2012; 160: 204-209.e3
- Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX).J Trauma Acute Care Surg. 2014; 77 ([discussion: 858]): 852-858
- Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.Semin Thromb Hemost. 2013; 39: 191-201
- Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated.Semin Thromb Hemost. 2011; 37: 35-40
- Management of acquired von Willebrand syndrome.Transfus Apher Sci. 2018; 57: 721-723
- Origins, development, current challenges and future directions with activated prothrombin complex concentrate for the treatment of patients with congenital haemophilia with inhibitors.Hamostaseologie. 2020; https://doi.org/10.1055/a-1159-4273
- Acquired haemophilia A: a 2013 update.Thromb Haemost. 2013; 110: 1114-1120
- Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.Haematologica. 2004; 89: ECR14
- Case report of an acquired factor XIII inhibitor: diagnosis and management.Proc (Bayl Univ Med Cent). 2006; 19: 221-223
- Transient hemorrhagic diathesis associated with an inhibitor of prothrombin with lupus anticoagulant in a 1 1/2-year-old girl: report of a case and review of the literature.Am J Hematol. 1996; 51: 307-314
- Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome.J Pediatr. 1997; 130: 998-1000
- Thrombosis in children: approach to anatomic risks, thrombophilia, prevention, and treatment.Hematol Oncol Clin North Am. 2019; 33: 439-453
- Neonatal venous thromboembolism.Front Pediatr. 2017; 5: 136
- Inherited thrombophilia in pediatric venous thromboembolic disease: why and who to test.Front Pediatr. 2017; 5: 50
- Thrombophilia in children: who to test, how, when, and why?.Hematology Am Soc Hematol Educ Program. 2008; : 228-235https://doi.org/10.1182/asheducation-2008.1.228
- Diagnosis and management of the antiphospholipid syndrome.N Engl J Med. 2018; 379: 1290
- The differences between childhood and adult onset antiphospholipid syndrome.Front Pediatr. 2018; 6: 362
- Anticoagulating patients with high-risk acquired thrombophilias.Blood. 2018; 132: 2219-2229
- How we treat paroxysmal nocturnal hemoglobinuria: a consensus statement of the Canadian PNH Network and review of the national registry.Eur J Haematol. 2019; 102: 36-52
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.Blood Adv. 2018; 2: 3360-3392
- American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.Blood Adv. 2018; 2: 3292-3316
- Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest Physicians evidence-based clinical Practice guidelines.Chest. 2012; 141: e737S-e801S
- Diagnosis and management of catastrophic antiphospholipid syndrome.Expert Rev Hematol. 2017; 10: 365-374
- Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.J Thromb Haemost. 2020; 18: 1672-1685
Article info
Publication history
Published online: December 14, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
